Lisbeth Fink

Lisbeth Fink is a highly experienced professional in the field of biotherapeutics and molecular pharmacology, currently serving as Senior Director of Biotherapeutics Screening at Ferring Pharmaceuticals since December 2022. Prior to this, Lisbeth held the position of VP of In Vitro & Pharmaceutical Research at Gubra, overseeing a team responsible for peptide chemistry, molecular pharmacology, and advanced technology platforms. Lisbeth has also held various roles at Novo Nordisk A/S, including Manager of Diabetes Complications Biology, where significant contributions were made to understanding diabetic nephropathy. Earlier academic positions include Assistant Professor at the Technical University of Denmark and postdoctoral research in renowned institutions. Lisbeth obtained a PhD in Immunology from the Technical University of Denmark, complemented by multiple master's degrees in immunology and dairy science, and a BSc in food science and technology.